Deadline: 11-Oct-22
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2023 AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF).
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures.
Funding Information
- HRSA estimates approximately $75,000,000 to be available to fund up to 25 recipients. If you have a current ADAP waiting list, you may apply for a ceiling amount of up to $10,000,000 total cost. If you do not have a current ADAP waiting list, you may apply for a ceiling amount of up to $7,000,000 total cost.
- The period of performance is April 1, 2023 through March 31, 2024 (1 year).
Eligibility Criteria
- All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the following requirements:
- Eligible applicants are limited to RWHAP Part B states/territories that need additional funding:
- to reduce or eliminate an existing ADAP waiting list,
- to actively prevent the implementation of an ADAP waiting list,
- to address a projected increase in treatment needs aligned with ending the HIV epidemic in the U.S., and/or
- to address other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage.
- Eligible applicants are limited to RWHAP Part B states/territories that need additional funding:
For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=340368